Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
<p>Abstract</p> <p>Background</p> <p>Circulating tumor cells (CTCs) are detectable in peripheral blood of metastatic breast cancer patients (MBC). In this paper we evaluate a new CTC separation method based on a combination of anti-EpCAM- and anti-cytokeratin magnetic c...
Main Authors: | Weissenstein Ulrike, Schumann Agnes, Reif Marcus, Link Susanne, Toffol-Schmidt Ulrike D, Heusser Peter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/12/206 |
Similar Items
-
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
by: Helen Schneck, et al.
Published: (2015-01-01) -
Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
by: Helen Schneck, et al.
Published: (2016-01-01) -
EpCAM as Modulator of Tissue Plasticity
by: François Fagotto
Published: (2020-09-01) -
Expression of EpCAM in uveal melanoma
by: Odashiro Alexandre N, et al.
Published: (2006-11-01) -
EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
by: Chantima, W, et al.
Published: (2017)